<DOC>
	<DOCNO>NCT01021592</DOCNO>
	<brief_summary>This observational study observe degree quality life patient multiple myeloma bortezomib administration use EORTC-QLQ C30 ( European Organization Research Treatment Cancer Quality Life Questionnaire-Core30 ) EQ-5D ( EuroQol-5 Dimensions ) . Both tool validate research instrument use measure quality life cancer patient consequently provide fundamental data regard quality life patient multiple myeloma analyze factor affect quality life .</brief_summary>
	<brief_title>Quality Life Multiple Myeloma Patients Treated With Bortezomib</brief_title>
	<detailed_description>Many clinical study treatment multiple myeloma conduct Korea , none evaluate improvement quality life patient multiple myeloma . Most study variable use evaluate quality life patient multiple myeloma subjective limit . This study observe degree change quality life patient multiple myeloma bortezomib administration use EORTC-C30 ( European Organization Research Treatment Cancer Quality Life Questionnaire-Core30 ) EQ-5D ( EuroQol-5 Dimensions ) , validate research instrument use measure quality life cancer patient consequently provide fundamental data regard quality life patient multiple myeloma.. Observational Study - No investigational drug administer</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Bortezomib</mesh_term>
	<criteria>Patients newly prescribe bortezomib injection secondary agent treatment multiple myeloma Patients understand fill quality life questionnaire , agree provide information include Patients hypersensitive bortezomib component bortezomib history hypersensitivity Patients severe hepatic impairment Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Velcade</keyword>
	<keyword>QoL</keyword>
	<keyword>Proteasome inhibitor</keyword>
	<keyword>Bortezomib</keyword>
	<keyword>EORTC QLQ C30</keyword>
	<keyword>EQ 5D</keyword>
</DOC>